{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T20:11:17Z","timestamp":1784664677340,"version":"3.55.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,10,3]],"date-time":"2016-10-03T00:00:00Z","timestamp":1475452800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12872-016-0367-3","type":"journal-article","created":{"date-parts":[[2016,10,3]],"date-time":"2016-10-03T10:52:25Z","timestamp":1475491945000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":53,"title":["A potential marker of bare metal stent restenosis: monocyte count - to- HDL cholesterol ratio"],"prefix":"10.1186","volume":"16","author":[{"given":"Fatih Mehmet","family":"Ucar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,10,3]]},"reference":[{"key":"367_CR1","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1016\/j.jacc.2010.07.028","volume":"56","author":"GD Dangas","year":"2010","unstructured":"Dangas GD, Claessen BE, Caixeta A, Sanidas EA, Mintz GS, Mehran R. In-stent restenosis in the drug-eluting stent era. J Am Coll Cardiol. 2010;56:1897\u2013907.","journal-title":"J Am Coll Cardiol"},{"key":"367_CR2","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1161\/01.CIR.79.6.1374","volume":"79","author":"MW Liu","year":"1989","unstructured":"Liu MW, Roubin GS, King 3rd SB. Restenosis after coronary angioplasty. Potential biologic determinants and role of intimal hyperplasia. Circulation. 1989;79:1374\u201387.","journal-title":"Circulation"},{"key":"367_CR3","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1161\/01.ATV.0000037100.44766.5B","volume":"22","author":"FG Welt","year":"2002","unstructured":"Welt FG, Rogers C. Inflammation and restenosis in the stent era. Arterioscler Thromb Vasc Biol. 2002;22:1769\u201376.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"367_CR4","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1189\/jlb.0206125","volume":"80","author":"P Ancuta","year":"2006","unstructured":"Ancuta P, Wang J, Gabuzda D. CD16+ monocytes produce IL-6, CCL2, and matrix metalloproteinase-9 upon interaction with CX3CL1-expressing endothelial cells. J Leukoc Biol. 2006;80:1156\u201364.","journal-title":"J Leukoc Biol"},{"key":"367_CR5","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/0005-2760(90)90314-N","volume":"1044","author":"S Parthasarathy","year":"1990","unstructured":"Parthasarathy S, Barnett J, Fong LG. High-density lipoprotein inhibits the oxidative modification of low-density lipoprotein. Biochim Biophys Acta. 1990;1044:275\u201383.","journal-title":"Biochim Biophys Acta"},{"key":"367_CR6","doi-asserted-by":"publisher","first-page":"375","DOI":"10.2217\/bmm-2015-0050","volume":"10","author":"MK Akboga","year":"2016","unstructured":"Akboga MK, Balci KG, Maden O, et al. Usefulness of monocyte to HDL-cholesterol ratio to predict high SYNTAX score in patients with stable coronary artery disease. Biomark Med. 2016;10:375\u201383.","journal-title":"Biomark Med"},{"key":"367_CR7","doi-asserted-by":"publisher","unstructured":"Akboga MK, Yayla C, Balci KG, et al. Relationship between serum albumin level and monocyte-to-high-density lipoprotein cholesterol ratio with saphenous vein graft disease in coronary bypass. Thorac Cardiovasc Surg. 2016. doi:\n                    10.1055\/s-0036-1582260\n                    \n                  . PMID:27111497.","DOI":"10.1055\/s-0036-1582260"},{"key":"367_CR8","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1093\/europace\/euu291","volume":"17","author":"U Canpolat","year":"2015","unstructured":"Canpolat U, Aytemir K, Yorgun H, et al. The role of preprocedural monocyte-to-high-density lipoprotein ratio in prediction of atrial fibrillation recurrence after cryoballoon-based catheter ablation. Europace. 2015;17:1807\u201315.","journal-title":"Europace"},{"key":"367_CR9","doi-asserted-by":"publisher","first-page":"967","DOI":"10.2217\/bmm.15.74","volume":"9","author":"EH Cetin","year":"2015","unstructured":"Cetin EH, Cetin MS, Canpolat U, et al. Monocyte\/HDL-cholesterol ratio predicts the definite stent thrombosis after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction. Biomark Med. 2015;9:967\u201377.","journal-title":"Biomark Med"},{"key":"367_CR10","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1161\/01.CIR.80.2.410","volume":"80","author":"E Braunwald","year":"1989","unstructured":"Braunwald E. Unstable angina. A classification. Circulation. 1989;80:410\u20134.","journal-title":"Circulation"},{"key":"367_CR11","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1002\/ccd.23438","volume":"79","author":"GN Levine","year":"2012","unstructured":"Levine GN, Bates ER, Blankenship JC, et al. 2011 ACCF\/AHA\/SCAI Guideline for Percutaneous Coronary Intervention: executive summary: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. Catheter Cardiovasc Interv. 2012;79:453\u201395.","journal-title":"Catheter Cardiovasc Interv"},{"key":"367_CR12","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1016\/S0735-1097(01)01344-4","volume":"37","author":"SC Smith Jr","year":"2001","unstructured":"Smith Jr SC, Dove JT, Jacobs AK, et al. ACC\/AHA guidelines of percutaneous coronary interventions (revision of the 1993 PTCA guidelines)--executive summary. A report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines (committee to revise the 1993 guidelines for percutaneous transluminal coronary angioplasty). J Am Coll Cardiol. 2001;37:2215\u201339.","journal-title":"J Am Coll Cardiol"},{"key":"367_CR13","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1161\/01.CIR.88.3.1310","volume":"88","author":"RE Kuntz","year":"1993","unstructured":"Kuntz RE, Baim DS. Defining coronary restenosis. Newer clinical and angiographic paradigms. Circulation. 1993;88:1310\u201323.","journal-title":"Circulation"},{"key":"367_CR14","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.jacc.2013.09.043","volume":"63","author":"G Campo","year":"2014","unstructured":"Campo G, Tebaldi M, Vranckx P, et al. Short- versus long-term duration of dual antiplatelet therapy in patients treated for in-stent restenosis: a PRODIGY trial substudy (Prolonging Dual Antiplatelet Treatment After Grading Stent-Induced Intimal Hyperplasia). J Am Coll Cardiol. 2014;63:506\u201312.","journal-title":"J Am Coll Cardiol"},{"key":"367_CR15","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1016\/j.jcin.2011.05.025","volume":"4","author":"T Inoue","year":"2011","unstructured":"Inoue T, Croce K, Morooka T, Sakuma M, Node K, Simon DI. Vascular inflammation and repair: implications for re-endothelialization, restenosis, and stent thrombosis. JACC Cardiovasc Interv. 2011;4:1057\u201366.","journal-title":"JACC Cardiovasc Interv"},{"key":"367_CR16","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1161\/01.CIR.99.1.44","volume":"99","author":"A Farb","year":"1999","unstructured":"Farb A, Sangiorgi G, Carter AJ, et al. Pathology of acute and chronic coronary stenting in humans. Circulation. 1999;99:44\u201352.","journal-title":"Circulation"},{"key":"367_CR17","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/S0735-1097(97)00450-6","volume":"31","author":"R Kornowski","year":"1998","unstructured":"Kornowski R, Hong MK, Tio FO, Bramwell O, Wu H, Leon MB. In-stent restenosis: contributions of inflammatory responses and arterial injury to neointimal hyperplasia. J Am Coll Cardiol. 1998;31:224\u201330.","journal-title":"J Am Coll Cardiol"},{"key":"367_CR18","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s10557-014-6569-y","volume":"29","author":"G Campo","year":"2015","unstructured":"Campo G, Pavasini R, Malagu M, et al. Chronic obstructive pulmonary disease and ischemic heart disease comorbidity: overview of mechanisms and clinical management. Cardiovasc Drugs Ther. 2015;29:147\u201357.","journal-title":"Cardiovasc Drugs Ther"},{"key":"367_CR19","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1161\/01.CIR.91.5.1320","volume":"91","author":"A Pietersma","year":"1995","unstructured":"Pietersma A, Kofflard M, de Wit LE, et al. Late lumen loss after coronary angioplasty is associated with the activation status of circulating phagocytes before treatment. Circulation. 1995;91:1320\u20135.","journal-title":"Circulation"},{"key":"367_CR20","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/S0008-6363(03)00355-9","volume":"60","author":"BM Rahel","year":"2003","unstructured":"Rahel BM, Visseren FL, Suttorp MJ, et al. Preprocedural serum levels of acute-phase reactants and prognosis after percutaneous coronary intervention. Cardiovasc Res. 2003;60:136\u201340.","journal-title":"Cardiovasc Res"},{"key":"367_CR21","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.amjcard.2005.08.024","volume":"97","author":"S Turker","year":"2006","unstructured":"Turker S, Guneri S, Akdeniz B, et al. Usefulness of preprocedural soluble CD40 ligand for predicting restenosis after percutaneous coronary intervention in patients with stable coronary artery disease. Am J Cardiol. 2006;97:198\u2013202.","journal-title":"Am J Cardiol"},{"key":"367_CR22","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.carrev.2008.01.003","volume":"9","author":"G Ferrante","year":"2008","unstructured":"Ferrante G, Niccoli G, Biasucci LM, et al. Association between C-reactive protein and angiographic restenosis after bare metal stents: an updated and comprehensive meta-analysis of 2747 patients. Cardiovasc Revasc Med. 2008;9:156\u201365.","journal-title":"Cardiovasc Revasc Med"},{"key":"367_CR23","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1093\/oxfordjournals.aje.a116601","volume":"137","author":"R Olivares","year":"1993","unstructured":"Olivares R, Ducimetiere P, Claude JR. Monocyte count: a risk factor for coronary heart disease? Am J Epidemiol. 1993;137:49\u201353.","journal-title":"Am J Epidemiol"},{"key":"367_CR24","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.imbio.2012.01.008","volume":"217","author":"A Gratchev","year":"2012","unstructured":"Gratchev A, Sobenin I, Orekhov A, Kzhyshkowska J. Monocytes as a diagnostic marker of cardiovascular diseases. Immunobiology. 2012;217:476\u201382.","journal-title":"Immunobiology"},{"key":"367_CR25","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1161\/01.RES.0000146094.59640.13","volume":"95","author":"PJ Barter","year":"2004","unstructured":"Barter PJ, Nicholls S, Rye KA, Anantharamaiah GM, Navab M, Fogelman AM. Antiinflammatory properties of HDL. Circ Res. 2004;95:764\u201372.","journal-title":"Circ Res"},{"key":"367_CR26","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1161\/01.ATV.15.11.1987","volume":"15","author":"GW Cockerill","year":"1995","unstructured":"Cockerill GW, Rye KA, Gamble JR, Vadas MA, Barter PJ. High-density lipoproteins inhibit cytokine-induced expression of endothelial cell adhesion molecules. Arterioscler Thromb Vasc Biol. 1995;15:1987\u201394.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"367_CR27","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1161\/ATVBAHA.108.168690","volume":"28","author":"AJ Murphy","year":"2008","unstructured":"Murphy AJ, Woollard KJ, Hoang A, et al. High-density lipoprotein reduces the human monocyte inflammatory response. Arterioscler Thromb Vasc Biol. 2008;28:2071\u20137.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"367_CR28","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1007\/s11255-014-0730-1","volume":"46","author":"M Kanbay","year":"2014","unstructured":"Kanbay M, Solak Y, Unal HU, et al. Monocyte count\/HDL cholesterol ratio and cardiovascular events in patients with chronic kidney disease. Int Urol Nephrol. 2014;46:1619\u201325.","journal-title":"Int Urol Nephrol"},{"key":"367_CR29","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1016\/j.amjcard.2015.08.036","volume":"116","author":"H Kundi","year":"2015","unstructured":"Kundi H, Gok M, Kiziltunc E, et al. Relation between monocyte to high-density lipoprotein cholesterol ratio with presence and severity of \u0131solated coronary artery ectasia. Am J Cardiol. 2015;116:1685\u20139.","journal-title":"Am J Cardiol"},{"key":"367_CR30","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1016\/j.jacc.2012.11.068","volume":"61","author":"RP Juni","year":"2013","unstructured":"Juni RP, Duckers HJ, Vanhoutte PM, Virmani R, Moens AL. Oxidative stress and pathological changes after coronary artery interventions. J Am Coll Cardiol. 2013;61:1471\u201381.","journal-title":"J Am Coll Cardiol"},{"key":"367_CR31","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.amjcard.2013.09.004","volume":"113","author":"O Turak","year":"2014","unstructured":"Turak O, Canpolat U, Ozcan F, et al. Usefulness of preprocedural serum uric acid level to predict restenosis of bare metal stents. Am J Cardiol. 2014;113:197\u2013202.","journal-title":"Am J Cardiol"},{"key":"367_CR32","doi-asserted-by":"publisher","first-page":"5698931","DOI":"10.1155\/2016\/5698931","volume":"2016","author":"SK Biswas","year":"2016","unstructured":"Biswas SK. Does the \u0131nterdependence between oxidative stress and \u0131nflammation explain the antioxidant paradox? Oxid Med Cell Longev. 2016;2016:5698931.","journal-title":"Oxid Med Cell Longev"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-016-0367-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12872-016-0367-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-016-0367-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,2,21]],"date-time":"2017-02-21T19:49:56Z","timestamp":1487706596000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-016-0367-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,3]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["367"],"URL":"https:\/\/doi.org\/10.1186\/s12872-016-0367-3","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,3]]},"article-number":"186"}}